Matthew W. Wilson
- Ophthalmology top 0.1%
- Oncology top 2%
- Molecular Biology top 10%
- Radiology, Nuclear Medicine and Imaging top 2%
- Surgery top 5%
- Co-authors
- Barrett G. HaikCarlos Rodríguez‐GalindoJohn L. HungerfordRachel C. BrennanDianna A. JohnsonMichael A. DyerIbrahim QaddoumiJames C. Fleming
- Topics
- Ocular Oncology and Treatments (100 papers)Cancer-related Molecular Pathways (19 papers)Glioma Diagnosis and Treatment (18 papers)
- Cited by
- OphthalmologyOncologyGenetics
- Partner nations
- United StatesArgentinaCanada
In The Last Decade
Matthew W. Wilson
148 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 137
- Ophthalmology 2.4k
- Oncology 1.3k
- Molecular Biology 1.0k
- Radiology, Nuclear Medicine and Imaging 691
- Surgery 550
Countries citing papers authored by Matthew W. Wilson
This map shows the geographic impact of Matthew W. Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew W. Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew W. Wilson more than expected).
Fields of papers citing papers by Matthew W. Wilson
This network shows the impact of papers produced by Matthew W. Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew W. Wilson. The network helps show where Matthew W. Wilson may publish in the future.
Co-authorship network of co-authors of Matthew W. Wilson
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew W. Wilson. A scholar is included among the top collaborators of Matthew W. Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew W. Wilson. Matthew W. Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 10 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 9 | |
| 7 | PDGF-PDGFR Signaling Sustain Angiogenesis in an Autocrine and Paracrine Fashion in Retinoblastoma | 1 |
| 8 | The Effects of Modulation of MMP-2 and MMP-9 in Angiogenesis and Invasive Potential in Retinoblastoma | 1 |
| 9 | 23 | |
| 10 | 85 | |
| 11 | Effects of Supra-Selective Intra-Ophthalmic Artery Chemotherapy (SSIOAC) on Orbital Arteries in a Non-Human Primate Model | 1 |
| 12 | 71 | |
| 13 | Exposure of Human Retinal Endothelial Cells to High Dose Chemotherapy Upregulates Inflammation and Chemotaxis | 1 |
| 14 | 98 | |
| 15 | 2 | |
| 16 | Long Term Survival in Patients With Large Ciliary Body and Choroidal Melanomas Treated With Iodine-125 Plaque Brachytherapy | 1 |
| 17 | 43 | |
| 18 | 32 | |
| 19 | 18 | |
| 20 | Carboplatin and Vincristine as Primary Systemic Chemotherapy for Intraocular Retinoblastoma: A Review of 82 Consecutively Treated Eyes. | 1 |
About Matthew W. Wilson
Matthew W. Wilson is a scholar working on Ophthalmology, Genetics and Oncology, having authored 160 papers that have together received 3.9k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (100 papers), Cancer-related Molecular Pathways (19 papers) and Glioma Diagnosis and Treatment (18 papers). The work is most often cited by research in Ophthalmology (2.4k citations), Oncology (1.3k citations) and Genetics (375 citations). Matthew W. Wilson has collaborated with scholars based in United States, Argentina and Canada. Frequent co-authors include Barrett G. Haik, Carlos Rodríguez‐Galindo, John L. Hungerford, Rachel C. Brennan, Dianna A. Johnson, Michael A. Dyer, Ibrahim Qaddoumi, James C. Fleming, Yevgeniy Shildkrot and Thomas E. Merchant. Their work appears in journals such as Nature, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.